SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-011933
Filing Date
2022-01-19
Accepted
2022-01-19 07:42:56
Documents
14
Period of Report
2022-01-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d129822d8k.htm   iXBRL 8-K 24536
2 EX-99.1 d129822dex991.htm EX-99.1 11367
6 GRAPHIC g129822g0119072117108.jpg GRAPHIC 3142
  Complete submission text file 0001193125-22-011933.txt   166398

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ymtx-20220119.xsd EX-101.SCH 2848
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ymtx-20220119_lab.xml EX-101.LAB 17995
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ymtx-20220119_pre.xml EX-101.PRE 11256
8 EXTRACTED XBRL INSTANCE DOCUMENT d129822d8k_htm.xml XML 3398
Mailing Address 40 GUEST STREET SUITE 4410 BOSTON MA 02135
Business Address 40 GUEST STREET SUITE 4410 BOSTON MA 02135 617-409-5300
YUMANITY THERAPEUTICS, INC. (Filer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37695 | Film No.: 22536803
SIC: 2834 Pharmaceutical Preparations